Related Experiment Video
Updated: May 23, 2025

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Targeting WEE1 in tumor-associated dendritic cells potentiates antitumor immunity via the cGAS/STING pathway
Ian-Ian Ng1, Zhihua Zhang2, Kaimin Xiao3
1State Key Laboratory of Molecular Oncology, School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
Abstract:
DNA damage profoundly affects cancer progression and immune cell function. While research primarily focuses on tumor cells, the effects of DNA damage on immune cells remain understudied. Here, we observe significant DNA damage in tumor-associated dendritic cells (TADCs), accompanied by the upregulation of the serine/threonine kinase WEE1, a crucial regulator of DNA damage repair. Interestingly, DNA damage also stimulates DC activation. WEE1 inhibition activates TADCs through the cGAS/STING pathway, increasing IL-12 and type I interferon expression, thus enhancing the antitumor immune response and improving tumor control. Additionally, WEE1 inhibition augments the efficacy of DC vaccines and synergizes with immune checkpoint blockade therapy. These findings highlight a pivotal role of WEE1 signaling in DNA damage repair in DCs within the tumor microenvironment, which in turn suppresses the antitumor immune response. Therefore, targeting WEE1 in DCs represents a promising approach to enhance T cell activation and improve the effectiveness of cancer immunotherapy.
Insights
DNA damage in tumor-associated dendritic cells (TADCs) suppresses antitumor immunity. Inhibiting WEE1 kinase in TADCs activates them, enhancing immune responses and improving tumor control, offering a new cancer immunotherapy strategy.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Oncology
Background:
- DNA damage impacts cancer progression and immune function, but its effects on immune cells are understudied.
- Tumor-associated dendritic cells (TADCs) exhibit DNA damage and upregulated WEE1 kinase, a DNA repair regulator.
- DNA damage can paradoxically stimulate dendritic cell (DC) activation.
Purpose of the Study:
- To investigate the role of WEE1 signaling in DNA damage repair within TADCs in the tumor microenvironment.
- To explore the therapeutic potential of targeting WEE1 in TADCs for enhancing antitumor immunity.
Main Methods:
- Observation of DNA damage and WEE1 expression in TADCs.
- Assessment of TADC activation via the cGAS/STING pathway.
- Evaluation of cytokine expression (IL-12, type I interferon) following WEE1 inhibition.
- Analysis of WEE1 inhibition's effects on DC vaccines and immune checkpoint blockade therapy.
Main Results:
- Significant DNA damage and WEE1 upregulation were observed in TADCs.
- WEE1 inhibition in TADCs led to activation via the cGAS/STING pathway.
- Inhibition increased IL-12 and type I interferon, boosting antitumor immune response and tumor control.
- WEE1 inhibition enhanced DC vaccine efficacy and synergized with immune checkpoint blockade.
Conclusions:
- WEE1 signaling in TADCs plays a critical role in DNA damage repair, suppressing antitumor immunity within the tumor microenvironment.
- Targeting WEE1 in DCs is a promising strategy to enhance T cell activation and improve cancer immunotherapy outcomes.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
The Tumor Microenvironment
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

